Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3′-deoxy-3′-fluorothymidine-Reference-Cited by-同舟云学术

Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3′-deoxy-3′-fluorothymidine

Published:2010-02 Issue:4 Volume:79 Page:587-595
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Paproski Robert J.,Young James D.,Cass Carol E.

Funder

Canadian Cancer Society Research Institute

Alberta Cancer Research Institute

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference40 articles.

1. Cancer of the pancreas: are we making progress? A review of studies in the US Oncology Research Network;Cartwright;Cancer Control,2008

2. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group;Moore;J Clin Oncol,2007

3. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines;Mackey;Cancer Res,1998

4. Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer;Farrell;Gastroenterology,2009

5. The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma;Spratlin;Clin Cancer Res,2004

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives;Expert Review of Clinical Pharmacology;2024-03-15

2. Chemoresistance in pancreatic ductal adenocarcinoma: Overcoming resistance to therapy;Advances in Cancer Research;2023

3. Role of human nucleoside transporters in pancreatic cancer and chemoresistance;World Journal of Gastroenterology;2021-10-28

4. Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer;Biomedicine & Pharmacotherapy;2021-10

5. Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells;Pharmaceutics;2020-02-07